inhibition cytohesins secinh3 leads hepatic insulin resistance
g proteins important class regulatory switches living systems activated guanine nucleotide exchange factors gefs facilitate exchange gdp gtp activity makes gefs attractive targets modulating disease-relevant g-protein-controlled signalling networks- gef inhibitors therefore interest tools elucidating function proteins therapeutic intervention however one small molecule gef inhibitor brefeldin bfa currently available- used aptamer displacement screen identify secinh3 small molecule antagonist cytohesins cytohesins class bfa-resistant small gefs adp-ribosylation factors arfs regulate cytoskeletal organization integrin activation integrin signalling application secinh3 human liver cells showed insulin-receptor-complex-associated cytohesins required insulin signalling secinh3-treated mice show increased expression gluconeogenic genes reduced expression glycolytic fatty acid ketone body metabolism genes liver reduced liver glycogen stores compensatory increase plasma insulin thus cytohesin inhibition results hepatic insulin resistance insulin resistance among earliest pathological changes type diabetes results show potential chemical biology dissecting molecular pathogenesis disease
